Literature DB >> 10438545

TRAIL death pathway expression and induction in thyroid follicular cells.

J D Bretz1, M Rymaszewski, P L Arscott, A Myc, K B Ain, N W Thompson, J R Baker.   

Abstract

To determine whether programmed cell death in thyroid follicular cells can be related to activation of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) pathway, we examined the expression and function of this pathway in primary thyroid follicular cells and a papillary thyroid carcinoma cell line in vitro. Despite the expression of TRAIL receptors death receptor 4 and death receptor 5, purified TRAIL could not induce programmed cell death (PCD) in any of the thyroid follicular cells examined. However, pre-incubation with cycloheximide before TRAIL facilitated the induction of rapid and massive PCD. This suggested that despite the presence of a labile inhibitor of the TRAIL pathway, TRAIL could mediate PCD under appropriate conditions. To determine whether there were sources of TRAIL in the thyroid that could interact with thyroid follicular cell TRAIL receptors, RNase protection assays were used to determine TRAIL mRNA expression. TRAIL message was expressed in intrathyroidal lymphocytes isolated from a patient with thyroiditis, and unexpectedly, thyroid follicular cells themselves could be induced to express abundant TRAIL message in the presence of the inflammatory cytokines interferon gamma, tumor necrosis factor alpha, and interleukin 1beta. Furthermore, the papillary thyroid carcinoma cell line could be induced to kill the TRAIL-sensitive lymphoma cell line BJAB through a TRAIL-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10438545     DOI: 10.1074/jbc.274.33.23627

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Cloning and characterization of chicken SPATA4 gene and analysis of its specific expression.

Authors:  Ming-Chao Xie; Chao Ai; Xiu-Mei Jin; Shang-Feng Liu; Shi-Xin Tao; Zan-Dong Li; Zhao Wang
Journal:  Mol Cell Biochem       Date:  2007-08-03       Impact factor: 3.396

2.  Alpha-fodrin as a putative autoantigen in Graves' ophthalmopathy.

Authors:  G J Kahaly; H Bang; W Berg; M Dittmar
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

Review 3.  Shared pathways: death receptors and cytotoxic drugs in cancer therapy.

Authors:  I Peták; J A Houghton
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

4.  Killing effect of TNF-related apoptosis inducing ligand regulated by tetracycline on gastric cancer cell line NCI-N87.

Authors:  X C Wei; X J Wang; K Chen; L Zhang; Y Liang; X L Lin
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

5.  Fas/FasL mediated apoptosis of thyrocytes in Graves' disease.

Authors:  N Sera; A Kawakami; T Nakashima; H Nakamura; M Imaizumi; T Koji; Y Abe; T Usa; T Tominaga; E Ejima; K Ashizawa; N Yokoyama; N Ishikawa; K Ito; K Eguchi
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

6.  Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells.

Authors:  Vassiliki Poulaki; Constantine S Mitsiades; Vassiliki Kotoula; Sophia Tseleni-Balafouta; Avi Ashkenazi; Demetrios A Koutras; Nicholas Mitsiades
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

Review 7.  Pro-inflammatory cytokine-mediated anemia: regarding molecular mechanisms of erythropoiesis.

Authors:  F Morceau; M Dicato; M Diederich
Journal:  Mediators Inflamm       Date:  2010-03-01       Impact factor: 4.711

8.  Tunicamycin enhances TRAIL-induced apoptosis by inhibition of cyclin D1 and the subsequent downregulation of survivin.

Authors:  Hai-Yan Zhang; Zhen-Xian Du; Bao-Qin Liu; Yan-Yan Gao; Xin Meng; Yifu Guan; Wei-Wei Deng; Hua-Qin Wang
Journal:  Exp Mol Med       Date:  2009-05-31       Impact factor: 8.718

9.  The role of MHC class I glycoproteins in the regulation of induction of cell death in immunocytes by malignant melanoma cells.

Authors:  D Fishman; B Irena; S Kellman-Pressman; M Karas; S Segal
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

Review 10.  Fas-FasL in Hashimoto's thyroiditis.

Authors:  G Stassi; A Zeuner; D Di Liberto; M Todaro; L Ricci-Vitiani; R De Maria
Journal:  J Clin Immunol       Date:  2001-01       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.